Showing results (171-180 of 357) with videos related to

Sort By:
Pageof 36
Clinical and Experimental Immunology|April 12, 2001
Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmissionL Kuhn, S Meddows-Taylor, G Gray, et al.
Anticancer Research|March 1, 1995
Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II studyM Clerici, S Bretti, A Celano, et al.
Tumori|April 30, 1994
Patterns of care and survival in non small cell lung cancer: 15 years' experience in a general hospitalM Clerici, D Panvini, V Torri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2009
Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosisM Saresella, A Rolland, I Marventano, et al.
The Journal of Hospital Infection|August 7, 2013
Continuous exposure to Kaposi sarcoma-associated herpesvirus (KSHV) in healthcare workers does not result in KSHV infectionR Mancuso, L Brambilla, V Boneschi, et al.
Psychoneuroendocrinology|January 1, 1997
A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virusM Clerici, D Trabattoni, S Piconi, et al.
Tumori|December 31, 1987
Radiotherapy versus radiotherapy plus cisplatin treatment for locally advanced non small cell lung cancer: preliminary results of a randomized studyM Clerici, E Soresi, R Zucali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigensM Clerici, N I Stocks, R A Zajac, et al.
AIDS (London, England)|September 21, 2000
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolateC Devito, J Hinkula, R Kaul, et al.
AIDS Research and Human Retroviruses|April 1, 1992
Brucella abortus stimulates human T cells from uninfected and HIV-infected individuals to secrete IFN gamma: implications for use of Brucella abortus as a carrier in development of human vaccinesR Blay, D Hernandez, M Betts, et al.
Pageof 36